S&P 500 7,586.34 -0.31% NASDAQ 26,991.68 -0.38% DOW 51,118.74 -0.37% VIX 16.23 +2.92%
Next Bullish Trade
MCK McKesson Corporation NYQ
$739.00 +2.22 (+0.30%)
Pullback · -1.32σ
+ Compare Set alert Open in Sniper

Price chart

Overlay: Click earnings ▲ markers for day-move details

Loading 1Y daily…

Financial overlay · last 12 quarters

QuarterRevenue Net incomeOp income FCFNet margin Op margin
2026-03-31 $96.3B $1.7B $2.2B $3.2B 1.7% 2.3%
2025-12-31 $106.2B $1.2B $1.7B $1.1B 1.1% 1.6%
2025-09-30 $103.2B $1.1B $1.5B $2.2B 1.1% 1.4%
2025-06-30 $97.8B $0.8B $1.1B $-1.1B 0.8% 1.1%
2025-03-31 $90.8B $1.3B $1.7B $7.5B 1.4% 1.8%
2024-12-31 $nanB $nanB $nanB $nanB nan% nan%
2024-09-30 $nanB $nanB $nanB $nanB nan% nan%

Earnings replay · last 20 reports

DateEPS actual EPS estSurprise
2026-05-07 11.69 11.57 +1.1%
2026-02-04 9.34 9.27 +0.7%
2025-11-05 9.86 9.05 +8.9%
2025-08-06 8.26 8.15 +1.4%
2025-05-08 10.12 9.83 +3.0%
2025-02-05 8.03 7.99 +0.5%
2024-11-06 7.07 6.87 +2.9%
2024-08-07 7.88 7.21 +9.3%
2024-05-07 6.18 6.36 -2.8%
2024-02-07 7.74 7.05 +9.8%
2023-11-01 6.23 6.15 +1.3%
2023-08-02 7.27 5.87 +23.9%
2023-05-08 7.19 7.12 +0.9%
2023-02-01 6.90 6.36 +8.4%
2022-11-01 6.06 6.10 -0.7%
2022-08-03 5.83 5.30 +10.1%
2022-05-05 5.83 6.04 -3.5%
2022-02-02 6.15 5.42 +13.6%
2021-11-01 6.15 4.66 +32.0%
2021-08-03 5.56 4.14 +34.3%

Earnings markers are overlaid on the price chart above. Transcript summaries require PERPLEXITY_API_KEY (deferred to a follow-up).

Peer comparison · Healthcare

Ticker ⇅ Mkt cap ⇅ P/E ⇅ Fwd P/E ⇅ P/S ⇅ EV/EBITDA ⇅ P/B ⇅ Gross M ⇅ Rev gr ⇅ EPS gr ⇅ FCF yld ⇅
MCK ★ $89B 19.2 14.7 0.2 13.8 -40.8 3.6% 6.0% 37.2% 6.37%
LLY $954B 37.9 24.1 13.2 27.3 30.6 82.8% 55.5% 169.9% 0.96%
UNH $350B 29.1 18.5 0.8 18.5 3.6 18.8% 2.0% 0.7% 5.05%
JNJ $539B 25.9 17.6 5.6 16.6 6.6 68.0% 9.9% -52.9% 2.32%
MRK $288B 32.8 12.2 4.4 11.2 6.3 76.7% 4.9% — 4.88%
ABBV $384B 105.9 13.4 6.1 14.8 -57.6 72.0% 12.4% -46.2% 5.43%
PFE $146B 19.5 9.0 2.3 7.8 1.6 74.8% 5.4% -10.1% 8.50%
TMO $175B 26.0 17.3 3.9 19.4 3.3 40.9% 6.2% 11.3% 3.15%

Auto-seeded from sector. Click any ticker to switch.

Ownership

Top institutional holders

Top-10 concentration: 38.3%

HolderShares% out
Blackrock Inc. 11,418,384 9.50%
Vanguard Capital Management LLC 7,960,724 6.62%
State Street Corporation 5,731,756 4.77%
FMR, LLC 3,603,423 3.00%
JPMORGAN CHASE & CO 3,268,340 2.72%
Franklin Resources, Inc. 3,063,145 2.55%
Geode Capital Management, LLC 2,903,848 2.42%
Massachusetts Financial Services Co. 2,900,233 2.41%
Vanguard Portfolio Management LLC 2,883,068 2.40%
Morgan Stanley 2,299,625 1.91%

Insider activity · 90d

No insider trades for MCK in last 90d.

Analyst estimates

yfinance
Low
$812.0
Mean
$949.73334
High
$1065.0
Analysts
15

Consensus: none (mean None). Distribution requires FINNHUB_API_KEY.

SEC filings

FormFiled DescriptionAction
4 2026-06-02 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES view ·
4 2026-06-01 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES view ·
4 2026-05-27 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES view ·
4 2026-05-27 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES view ·
4 2026-05-27 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES view ·
4 2026-05-27 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES view ·
4 2026-05-27 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES view ·
4 2026-05-27 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES view ·
4 2026-05-27 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES view ·
4 2026-05-26 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES view ·
4 2026-05-26 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES view ·
4 2026-05-26 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES view ·
4 2026-05-26 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES view ·
4 2026-05-26 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES view ·
4 2026-05-26 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES view ·
4 2026-05-26 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES view ·
4 2026-05-22 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES view ·
4 2026-05-22 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES view ·
4 2026-05-22 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES view ·
4 2026-05-22 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES view ·
4 2026-05-22 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES view ·
4 2026-05-22 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES view ·
4 2026-05-22 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES view ·
4 2026-05-21 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES view ·
4 2026-05-21 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES view ·
4 2026-05-21 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES view ·
4 2026-05-21 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES view ·
4 2026-05-21 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES view ·
4 2026-05-21 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES view ·
4 2026-05-21 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES view ·
10-K 2026-05-08 10-K view ·
8-K 2026-05-07 8-K view ·
8-K 2026-04-28 8-K view ·
8-K 2026-04-06 8-K view ·
8-K 2026-03-06 8-K view ·
8-K 2026-03-05 8-K view ·
4 2026-03-04 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES view ·
4 2026-02-23 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES view ·
4 2026-02-18 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES view ·
4 2026-02-13 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES view ·
4 2026-02-12 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES view ·
4 2026-02-11 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES view ·
4 2026-02-09 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES view ·
10-Q 2026-02-04 10-Q view ·
8-K 2026-02-04 8-K view ·
4 2026-01-06 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES view ·
4 2025-11-10 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES view ·
10-Q 2025-11-06 10-Q view ·
8-K 2025-11-05 8-K view ·
8-K 2025-09-23 8-K view ·
8-K 2025-09-18 8-K view ·
4 2025-08-25 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES view ·
4 2025-08-19 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES view ·
4 2025-08-11 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES view ·
10-Q 2025-08-06 10-Q view ·
8-K 2025-08-06 8-K view ·
8-K 2025-08-01 8-K view ·
4 2025-07-31 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES view ·
4 2025-07-31 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES view ·
4 2025-07-31 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES view ·

About

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; and provides logistics and distribution services for manufacturers. It also provides consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies; gene therapy with InspiroGene, practice consulting, and vaccine distribution services; and technology solutions, as well as research, insights, technologies, and services to improve cancer and specialty care. In addition, the company helps in solving medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Further, it of…